# Company Reports

This directory contains research on AI drug discovery companies.

## Company Index

| Company | Focus | Stage | Key Drug |
|---------|-------|-------|----------|
| Insilico Medicine | AI drug discovery | Phase II | ISM001-055 |
| Exscientia | AI-driven compound optimization | Phase I | EXS21546 |
| Recursion | High-throughput phenotypic screening | Phase II | REC-994 |
| AbCellera | Antibody discovery | Approved | Bamlanivimab |

## How to Add Reports

1. Research company public information
2. Create case study markdown file
3. Cite press releases and SEC filings
4. Include pipeline data

## Usage Guidelines

- Use publicly available information only
- Cite press releases and official sources
- Note dates of information

*Part of the Library of Alexandria*
